Evidence map›Paper›PMID 35269867›Full record

ArticleInternational journal of molecular sciences2022

pH Responsive

Sobia Noreen, Sara Hasan, Shazia Akram Ghumman, Syed Nasir Abbas Bukhari, Bushra Ijaz, Huma Hameed, Huma Iqbal, Afeefa Aslam, Mervat Abdelaziz Mohamed Elsherif, Shazia Noureen and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sobia NoreenInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.ORCID 0000-0002-0815-2223
Sara HasanInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Shazia Akram GhummanCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Syed Nasir Abbas BukhariDepartment of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0001-8125-7972
Bushra IjazCentre of Excellence in Molecular Biology, University of the Punjab, Lahore 54000, Pakistan.
Huma HameedIRSET, EHSEP, INSERM, University of Rennes 1, 35000 Rennes, France.
Huma IqbalInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Afeefa AslamCollege of Pharmacy, University of Sargodha, Sargodha 40100, Pakistan.
Mervat Abdelaziz Mohamed ElsherifChemistry Department, College of Science, Jouf University, Sakaka 42421, Saudi Arabia.
Shazia NoureenInstitute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan.
Hasan EjazDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0000-0002-6185-2042

Funding

Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia 375213500
6 · The paper itself

Abstract

The rapid progression in biomaterial nanotechnology apprehends the potential of non-toxic and potent polysaccharide delivery modules to overcome oral chemotherapeutic challenges. The present study is aimed to design, fabricate and characterize polysaccharide nanoparticles for methotrexate (MTX) delivery. The nanoparticles (NPs) were prepared by

Indexed as

AbelmoschusAntineoplastic AgentsChitosanNanoparticlesDrug CarriersDrug LiberationHydrogen-Ion ConcentrationMethotrexateParticle SizeAntineoplastic AgentsChitosanDrug CarriersMethotrexateanticancer drugantitumor activitybiopolymerin-vivo toxicitypH-responsivenesssustained delivery

Identifiers

PMID35269867
PMCPMC8910941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.